64406-020 NDC - VUMERITY (DIROXIMEL FUMARATE)

Drug Information

Product NDC: 64406-020

Proprietary Name: Vumerity

Non Proprietary Name: diroximel fumarate

Active Ingredient(s):
  • 231 mg/1 DIROXIMEL FUMARATE


Administration Route(s): ORAL

Dosage Form(s): CAPSULE

Labeler Information

Labeler Name: Biogen Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA211855
Marketing Category: NDA
Start Marketing Date:10/29/2019

Package Information

No. Package Code Package Description Billing Unit
164406-020-011 BOTTLE, PLASTIC in 1 CARTON (64406-020-01) / 106 CAPSULE in 1 BOTTLE, PLASTICEA
264406-020-031 BOTTLE, PLASTIC in 1 CARTON (64406-020-03) / 120 CAPSULE in 1 BOTTLE, PLASTICEA
364406-020-051 BOTTLE, PLASTIC in 1 CARTON (64406-020-05) / 106 CAPSULE in 1 BOTTLE, PLASTIC
464406-020-071 BOTTLE, PLASTIC in 1 CARTON (64406-020-07) / 14 CAPSULE in 1 BOTTLE, PLASTIC

NDC Record

Field Name Field Value Definition
PRODUCT NDC64406-020The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEVumerityThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEdiroximel fumarateThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECAPSULEThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE10/29/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMENDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERNDA211855This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEBiogen Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEDIROXIMEL FUMARATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH231 
ACTIVE INGRED UNITmg/1 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023